Friday, January 04, 2013

Lucentis - Roche and NICE see eye to eye after a price cut

The extent of the price cut in Lucentis is unknown, as it is covered by a confidentiality agreement between pharma companies and the government. But Roche has confirmed that a new lower price will apply to the drug in both wet AMD and DMO.

Anyone know the price cut?

No comments: